Stockreport

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial Results [Yahoo! Finance]

Dianthus Therapeutics, Inc.  (DNTH) 
PDF IND for Phase 2 MoMeNtum trial in Multifocal Motor Neuropathy (MMN) cleared by FDA in June; top-line results anticipated in 2H'26 Phase 2 trial in Chronic Inflammator [Read more]